Pfizer (NYSE:PFE)

Major Pharma Sees Fading Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Bull/Bear Outlook for 2019: How All 30 Dow Stocks Could Take the Market Up to 28,000

As 2019 gets into gear, there is a simple question that comes with a very difficult answer. Is the bull market that has raged since March of 2009 dead, or ...
Read Full Story »

Meet the 2019 Dogs of the Dow

Investors love their dividends. It was no secret that the bull market’s strength and reputation heading into the end of 2018 was tarnished. In fact, on the last trading day ...
Read Full Story »

Short Sellers Hike Bets in Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

The Bottom May Finally Be Near: 6 Dividend Stocks to Buy for 2019

After one of the most brutal sell-offs in years, it’s very possible that we are close to the bottom. On Monday, while the markets were getting strafed again, to the ...
Read Full Story »

Meet Pfizer and GlaxoSmithKline’s New Joint Venture

GlaxoSmithKline PLC (NYSE: GSK) shares bounced higher on Wednesday after the company announced a new joint venture with Pfizer Inc. (NYSE: PFE). These two firms will create a premier global ...
Read Full Story »

6 Most Important Business News Items Today

A new investigation shows Facebook Inc. (NASDAQ: FB) secretly released user data. According to The New York Times: For years, Facebook gave some of the world’s largest technology companies more ...
Read Full Story »

History Says Santa Claus Rally May Still Be on Its Way

Despite the horrible performance in December so far, with the S&P 500 down over 6%, past history says that the time-honored Santa Claus rally typically comes in the latter half ...
Read Full Story »

Major Pharma Stocks See a Surge in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Apptio, AT&T, Bain Capital, Comerica, First Solar, Palo Alto, Pfizer, Travelers, Ulta Beauty and More

Stocks managed to recover handily from Monday's losses and the futures were indicated to open higher by over 1% for the Dow Jones industrials, S&P 500 and Nasdaq on Tuesday ...
Read Full Story »

Short Sellers Hike Their Bets in Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

High Debt Maturities Bring Risk to the Endless Stock Buyback Addiction After 2018

Now that 2018 is nearing an end, it is a serious time for investors to start thinking about expectations in 2019 rather than looking back at how choppy 2018 has been. ...
Read Full Story »

With Long Bull Market Almost Over, Time to Rotate to Safety and Income

The hallmark of one of the longest bull markets in history has been the emergence and leadership of the FANG stocks, or Facebook, Amazon, Netflix and Google (now Alphabet). These ...
Read Full Story »

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

The treatment of erectile dysfunction (ED) has helped literally tens of millions of men in America alone. The number of drugs treating ED has grown substantially over the years, and ...
Read Full Story »